Maxnerva Technology Services Limited (01037) Reports February 2026 Equity Movements

Bulletin Express
03/03

For the month ended 28 February 2026, the authorized share capital remained at 1,000.00 million shares with a par value of HKD 0.10 each, totaling HKD 100.00 million. The total number of issued ordinary shares stood at 706.17 million, and no changes were recorded in the issued share capital or treasury shares during the month.

The public float continued to meet the 25% regulatory requirement. Share options granted on 31 August 2017, 12 November 2018, and 9 April 2022 showed no changes during the period, with no additional shares issued. No warrants, convertibles, or other agreements caused any alterations in the share capital.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10